4//SEC Filing
Martin Gilles Gerard Jean 4
Accession 0001179110-20-005866
CIK 0001109354other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 2:50 PM ET
Size
15.2 KB
Accession
0001179110-20-005866
Insider Transaction Report
Form 4
BRUKER CORPBRKR
Martin Gilles Gerard Jean
Director
Transactions
- Exercise/Conversion
Common Stock
2020-05-11$21.74/sh+10,000$217,400→ 24,657 total - Exercise/Conversion
Common Stock
2020-05-11$19.12/sh+10,000$191,200→ 34,657 total - Exercise/Conversion
Common Stock
2020-05-11$24.00/sh+10,000$240,000→ 44,657 total - Exercise/Conversion
Stock Option (Right to Purchase)
2020-05-11−10,000→ 0 totalExercise: $21.74From: 2017-02-10Exp: 2024-02-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2020-05-11−10,000→ 0 totalExercise: $24.00From: 2019-01-05Exp: 2026-01-05→ Common Stock (10,000 underlying) - Sale
Common Stock
2020-05-11$38.83/sh+30,000$1,164,951→ 14,657 total - Exercise/Conversion
Stock Option (Right to Purchase)
2020-05-11−10,000→ 0 totalExercise: $19.12From: 2018-01-05Exp: 2025-01-05→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.25, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
BRUKER CORP
CIK 0001109354
Entity typeother
Related Parties
1- filerCIK 0001597047
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 2:50 PM ET
- Size
- 15.2 KB